Harbin Medical University, Harbin, 150001, Heilongjiang, China,
Arch Gynecol Obstet. 2014 Aug;290(2):223-31. doi: 10.1007/s00404-014-3231-7. Epub 2014 Apr 18.
Amniotic fluid mesenchymal stem cells (AF-MSCs) are promising candidates for cell-based therapy. This review presents a comprehensive overview of the features and therapeutic applications of these cells.
This is a literature review combined with experience of practice.
Although the long-term risks of AF-MSCs require further investigation, these cells are increasing in popularity in the fields of regenerative medicine and targeting therapy because of their unique properties.
羊水间充质干细胞(AF-MSCs)是细胞治疗有前途的候选者。本文综述了这些细胞的特征和治疗应用。
这是文献综述与实践经验的结合。
尽管 AF-MSCs 的长期风险需要进一步研究,但由于其独特的特性,这些细胞在再生医学和靶向治疗领域越来越受欢迎。